Tag: Patient Care
-
Most Common Lung Function Test Misses Lung Disease in Many Black U.S. Adults
The most common test to measure a person’s lung function may be missing many people with impaired lung health, according to a new study.
-
Crohn’s Antibodies Equally Effective
Two new treatments for Crohn’s disease showed roughly equal performance in a clinical trial.
-
Weekly Symptom Monitoring Improves Quality of Life in Cancer
In adult patients undergoing cancer treatment, weekly electronic symptom monitoring significantly improved quality of life, according to a recent study published in JAMA.
-
Reducing Blood Cultures and Antibiotics in Pediatrics
Multidisciplinary diagnostic stewardship programs safely decreased blood culture collection and antibiotics for pediatric intensive care patients, according to findings published in JAMA Pediatrics.
-
Dissolving Implantable Device Relieves Pain Without Drugs
A Northwestern University-led team has developed a small, pain-relieving implant that could provide a much-needed alternative to opioids and other highly addictive medications.
-
Combination Treatment May Improve Quality of Life in Kidney Cancer
Patients with advanced kidney cancer who received a new combination treatment reported improved health-related quality of life outcomes, according to a Northwestern Medicine study.
-
Feinberg Offers Medical Spanish Courses for Students
Medical students and students in the Physician Assistant Program can advance their Spanish speaking skills by completing Medical Spanish courses in their respective programs.
-
Pursuing Deeper Understanding about the Most Common Type of Heart Failure
Of the estimated five million patients in the U.S. diagnosed with heart failure annually, nearly half will have heart failure with preserved ejection fraction (HFpEF) and at the forefront of HFpEF research are Feinberg investigators.
-
Intensive Crohn’s Treatment is Safe
Intensive treatment for patients with Crohn’s disease showed no safety differences compared to the current standard of care.
-
Genomic Variant May Predict Cardiotoxicity From Chemotherapy
A team of investigators have discovered a novel genomic variant that may help clinicians predict which patients will experience cardiotoxicity from a widely used chemotherapy drug, according to a Northwestern Medicine study.
